Prehabilitation is a multimodal strategy involving physical exercise as well as nutritional and psychosocial interventions aimed at improving fitness in the preoperative period. It is also used to improve and support patient tolerance and outcomes from treatments such as chemotherapy, radiotherapy, and immunotherapy.

Join a multidisciplinary team of nursing and allied health professionals as they discuss how prehabilitation can be used to optimize thoracic oncology patients prior to treatment and support them throughout their journey. This is part two of a two-part series that aims to comprehensively present the key aspects of prehabilitation, including a scientific overview of benefits, organizing a program, physical conditioning and strengthening strategies prior to and during treatment, nutritional support, and psychological/motivational support.

These webinars aim to address not only the reasons why prehabilitation is pivotal to optimizing patient care, and survivorship, but the wider scope of its implementation in the thoracic oncology cancer pathway. 

This webinar is designed to meet the educational needs of physicians, researchers, patient advocates, and nurse and allied health professionals specializing in palliative care, medical oncology, radiation oncology, and thoracic surgery.

Upon completion of this activity, the participants should be able to: 

• Summarize the rationale and evidence behind prehabilitation. This will include beneficial outcomes as functional capacity and reduced hospital stay.
• Describe objective measures used to determine functional capacity in patients with lung cancer.
• Describe the role nutrition plays in the care of lung cancer patients before, during, and after treatment.
• Explain the emotional concerns lung cancer patients may have related to pre-habilitation and describe supportive strategies.

Moderator:

• Pippa Labuc, BScOT, Clinical Specialist Occupational Therapist, Guy's and St. Thomas' NHS Foundation Trust London, United Kingdom

Presenters:

• Dr. Morten Quist, PT, PhD, Associate Professor, Body & Cancer, University of Copenhagen, University Hospital of Copenhagen, Rigshospitalet Copenhagen, Denmark
• Dr. Stephen Wootton, PhD, FAfN, OBE, Associate Professor, Human Nutrition, Deputy Chair, National Institute of health research Cancer & Nutrition Collaboration, University of Southampton, Southampton, England
• Dr. Christina Prickett, DPsych, Clinical Psychologist, Peter MacCallum Cancer Centre Melbourne, Australia

The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

If you need assistance with this activity, please email: education@iaslc.org.